AN IMPROVED SYNTHESIS OF (+/-)-DIHYDROACTINIDIOLIDE

DOI: 10.1016/S0040-4039(00)93483-X

Source and publish data:

Tetrahedron Letters p. 4871 - 4874 (1991)

Update date:2022-08-17

Topics:

Authors:

Subbaraju, Gottumukkala V.

Manhas, Maghar S.

Bose, Ajay K.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0040-4039(00)93483-X

An improved synthesis of (+/-)-aeginetolide (2) and (+/-)-dihydroactinidiolide (1) from 2,6,6-trimethyl-1-cyclohexene-1-acetaldehyde (4) has been achieved.

Full text of DOI:10.1016/S0040-4039(00)93483-X

Products guided by the article

Product name:DIHYDROACTINIDIOLIDE

Cas No:15356-74-8

R&D Labs maybe for 15356-74-8

Taizhou Crene Biotechnology co.ltd

Contact:86-576-88813233 88205808

Address:Economic Developed Zone of Taizhou Zhejiang China
hangzhou sunchem trading co., ltd.

Contact:13588470430--

Address:Room 406-407, the 4th Building, No549
Shanghai Yingrui Biopharma Co., Ltd

Contact:021-3358 8661*8003

Address:shanghai
Beijing Zhongshuo Pharmaceutical T & D Co.,Ltd

Contact:0086-10-64430626

Address:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
Hangzhou innopharma technology Co,.Ltd.(expird)

Contact:+86-13388601988

Address:Room845,lixin building, moganshan road, hangzhou, china

Relevant to this article

An efficient synthesis of enantiomeric (S)-phosphocarnitine

Doi:10.1002/1099-0690(200208)2002:16<2758::AID-EJOC2758>3.0.CO;2-Q
(2002)
Design, synthesis, and biological evaluation of novel aminopyrimidinylisoindolines as AXL kinase inhibitors

Doi:10.1016/j.bmcl.2018.10.013
(2018)
A concise synthesis of topsentin A and nortopsentins B and D.

Doi:10.1021/ol000124g
(2000)
Electrochemical reductive amination of furfural-based biomass intermediates

Doi:10.1039/c6gc01541g
(2016)
Use of nuclear magnetic resonance contact shifts to study the stability of paramagnetic coordination complexes. Bis(2,4-pentanedionato)nickel(II) complexes of substituted anilines

Doi:10.1021/ic50088a043
(1970)
Design and synthesis of novel PARP-1 inhibitors based on pyridopyridazinone scaffold

Doi:10.1016/j.bioorg.2019.03.068
(2019)

Article Doi